GenMark Diagnostics, A Member of the Roche Group, Scientific and Medical Affairs, Carlsbad, CA, United States.
Front Cell Infect Microbiol. 2022 Jul 13;12:841825. doi: 10.3389/fcimb.2022.841825. eCollection 2022.
During the initial onset of the COVID-19 pandemic, each industry experienced hardships. One area that has not been explored in great detail was how the diagnostic industry managed while bringing SARS-CoV-2 tests to the market. This perspective piece provides a sample view of what went on behind the walls of a diagnostic manufacturer that released one of the initial SARS-CoV-2 testing options, some of the barriers that were encountered, and how they could be overcome.
在 COVID-19 大流行的初期,每个行业都经历了困难。有一个领域没有被详细探讨过,那就是诊断行业在将 SARS-CoV-2 检测推向市场的过程中是如何管理的。这篇观点文章提供了一个示例,展示了一家诊断制造商在推出最初的 SARS-CoV-2 检测选项之一时的幕后情况,以及他们遇到的一些障碍以及如何克服这些障碍。